Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”

Case Reports in Rheumatology

doi 10.1155/2015/436736

Full Text

Abstract

Available in

Date

January 1, 2015

Authors

Jean-Christophe Delain

Jean-Charles Crave

Publisher

Hindawi Limited

Related search

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis

Case Reports in Rheumatology

English

High-Dose Intravenous Immunoglobulins for the Treatment of Dermatological Autoimmune Diseases

JDDG - Journal of the German Society of Dermatology

English

Treatment of Recurrent & Resistant Dermatomyositis / Polymyositis

Egyptian Journal of Rheumatology and Clinical Immunology

English

Subcutaneous Immunoglobulins Are a Valuable Treatment Option in Myasthenia Gravis

Journal of Clinical Neurology (Korea

English

Prognosis and Treatment of Polymyositis With Particular Reference to Steroid Resistant Patients.

Archives of Disease in Childhood

English

High-Dose Glucocorticoid for the Treatment of Myeloid Sarcoma

Journal of Leukemia

English

High-Dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii

The Korean Journal of Critical Care Medicine

English

Implications of Treatment Resistant Severe Psoriasis for Benchmarking Quality of Care

Journal of Dermatological Treatment

English

Adjuvant Treatment of Severe Varicella Pneumonia With Intravenous Varicella Zoster Virus-Specific Immunoglobulins

International Journal of Infectious Diseases

Infectious Diseases

English